listed company directors and actual controllers, including diving medical group vice chairman, gold mantis group director, sea silver's deputy chairman, WuNiu fund chairman, etc.

CQY capital currently manages 5 billion yuan, mainly in the private equity business. Investment areas include healthcare, big health, culture and entertainment, TMT and fintech.

CQY capital was established in August 2016. In the field of culture and entertainment, the company has invested in bona film, MOE books and lime film three large a-share pre-ipo projects. In the field of medical health, the company invests in Flycor Biomedical, the world's leading allergen detection equipment company. Meanwhile, a 3.17 billion yuan cinema acquisition fund was established in 2017.

The core concept ofCQY capital is to gather all kinds of perseverance to create the most valuable fund for investors. In the future, the company will also expand diversified businesses such as securities investment, mezzanine investment, merger and acquisition fund and wealth management, and strive to become a new rising star in China's financial industry.